REMIZY
LIVE

Serial Number

50012281

Owner

Axsome Therapeutics, Inc.

Attorney

Brent A. Johnson

Filing Date

Jul 24, 2026

Add to watchlist:

No watchlists yet
View on USPTO

REMIZY Trademark

Serial Number: 50012281

REMIZY is a trademark filed by Axsome Therapeutics, Inc. on July 24, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Axsome Therapeutics, Inc. (79 trademarks)

New York, NY 10007

Entity Type: 03

Trademark Details

Filing Date

July 24, 2026

Registration Date

Not Registered

Published for Opposition

September 29, 2026

Goods & Services

Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, cataplexy in narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, hair loss, epilepsy and tourette's schizophrenia

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 24, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Aug 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Aug 20, 2026 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 24, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2026 NWOS
NEW APPLICATION ENTERED
Jul 24, 2026 NWAP